Skip to main content
Home
  • About Mainstay
  • About Reactiv8
  • For Clinicians
  • Home
  • Investors
  • News & Events
  • Careers
  • Contact Us
  • EN
  • FR
  • DE
  • NL
  • US
  • AU
Sub menu▸
  • OVERVIEW
  • Results and Presentations
  • News
  • Governance
    • Corporate Governance
    • Board of Directors
    • Leadership Team
    • Board Committees
    • AGM
    • Documents relating to proposed delisting transaction and related shareholder meetings on 8 May
    • Documents relating to February 2021 EGM
  • Shareholder Information
  • Contact Us

AGM

2019 AGM

  • Notice of 2019 Annual General Meeting
  • Annual Report for the year ended 31 December 2018

2018 AGM

Click here for more information ▾
  • Notice of 2018 Annual General Meeting
  • Annual Report for the year ended 31 December 2017

2017 AGM

Click here for more information ▾
  • Notice of 2017 Annual General Meeting
  • Annual Report for the year ended 31 December 2016
  • Amended Articles of Association

2016 AGM

Click here for more information ▾
  • Notice of 2016 Annual General Meeting
  • Annual Report for the year ended 31 December 2015

2015 AGM

Click here for more information ▾
  • Notice of 2015 Annual General Meeting
  • Annual Report for the year ended 31 December 2014
  • Amended Memorandum and Articles of Association
Last Updated on 13th August 2019

© Copyright 2020 Mainstay Medical Limited. All rights reserved.

Footer menu

  • Site Map
  • Contact Us
  • Impressum
  • Privacy Policy
  • Terms & Conditions
  • Commercial Terms & Conditions

ReActiv8 is CE marked for the treatment of chronic low back pain and available for sale in Europe.

Disclaimer

I am in the United States, Canada, Japan or Australia.

Show